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ABSTRACT: TYW1 is a radical S-adenosyl-L-methionine (SAM) enzyme that
catalyzes the condensation of pyruvate and N-methylguanosine to form the
posttranscriptional modiﬁcation, 4-demethylwyosine, in situ on transfer RNA
(tRNA). Two mechanisms have been proposed for this transformation, with one
of the possible mechanisms invoking a Schiﬀ base intermediate formed between a
conserved lysine residue and pyruvate. Utilizing a combination of mass
spectrometry and X-ray crystallography, we have obtained evidence to support
the formation of a Schiﬀ base lysine adduct in TYW1. When 13C labeled pyruvate
is used, the mass shift of the adduct matches that of the labeled pyruvate,
indicating that pyruvate is the source of the adduct. Furthermore, a crystal
structure of TYW1 provides visualization of the Schiﬀ base lysine−pyruvate
adduct, which is positioned directly adjacent to the auxiliary [4Fe−4S] cluster.
The adduct coordinates the unique iron of the auxiliary cluster through the lysine
nitrogen and a carboxylate oxygen, reminiscent of how the radical SAM [4Fe−4S]
cluster is coordinated by SAM. The structure provides insight into the binding site
for tRNA and further suggests how radical SAM chemistry can be combined with
Schiﬀ base chemistry for RNA modiﬁcation.
■ INTRODUCTION
In addition to the four canonical RNA bases, transfer RNA
(tRNA) molecules are adorned with a wide variety of
posttranscriptionally modiﬁed bases, which range in complexity
from methylations to hypermodiﬁcations and may require the
actions of several enzymes, such as the eight-step trans-
formation involved in the biosynthesis of the modiﬁed base,
queuosine.1−8 These modiﬁcations expand the chemical
repertoire of nucleobases and have also been implicated in
the stabilization of tRNA structure and the maintenance of
function.9,10 In fact, many hypermodiﬁed bases occur at or
adjacent to the anticodon loop, where they are thought to be
involved in modulating codon−anticodon interaction or
stability.11 The nucleoside wyosine is a hypermodiﬁed base
that contains a characteristic imidazopurine (tricyclic) core
(Scheme 1).12−15 Wyosine derivatives are found at position 37
of the anticodon stem loop (ACSL) of tRNAPhe molecules from
archaea and eukarya.16−18 The presence of the large hydro-
phobic bulky base in position 37, which is adjacent to the
wobble base in the anticodon loop, has been shown to be
important in preventing frameshifts.19,20
The simplest wyosine derivative, 4-demethylwyosine (imG-
14), is found as both a modiﬁed tRNA base in some archaeal
species and an intermediate on the pathway to more complex
wyosine derivatives12,16−18,21−29 (Scheme 1). In vivo, imG-14 is
biosynthesized from guanosine by the successive actions of two
enzymes, the S-adenosyl-L-methionine (SAM) dependent
methyl transferase TRM5 and the radical SAM enzyme
TYW1.17,18,30,31 TRM5 methylates the genetically encoded
guanosine residue at N1 creating N-methylguanosine
(m1G),30,31 whereas TYW1 adds C2 and C3 of pyruvate to
m1G via a radical mechanism, forming the characteristic
tricyclic ring of all wyosine derivatives.32−37 The identity of
pyruvate as the source of the carbons in the imidazoline ring
was established using 13C pyruvate isotopologues in vitro, which
showed that C2 and C3 of pyruvate are incorporated into the
tRNA base and C1 is lost as an unidentiﬁed side product,
proposed to be either carbon dioxide or formate.33
TYW1, like other enzymes in the 100,000-plus membered
radical SAM superfamily,38 uses a SAM-bound [4Fe−4S]
cluster to reductively cleave SAM, forming methionine and a
highly reactive 5′-deoxyadenosyl radical species (dAdo•) that
initiates radical-based chemistry.39 TYW1 also has an auxiliary
iron−sulfur cluster, identiﬁed as a [4Fe−4S] cluster by an
electron paramagnetic resonance (EPR) and Mössbauer
study.35 Additional or auxiliary iron−sulfur clusters have been
identiﬁed in several characterized radical SAM enzymes
involved in the biosynthesis of cofactors (e.g., biotin,40 lipoic
acid,41,42 and the molybdopterin cofactor43) and antibiotics,44
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in the posttranslational modiﬁcation of proteins,45,46 and in
posttranscriptional modiﬁcations of RNA.47,48 A small subset of
these enzymes also contain auxiliary [4Fe−4S] clusters that are
ligated by three cysteine residues, leaving a site diﬀerentiated
iron ion. In these cases, the enzymes are predicted to use the
open coordination site to bind substrate, as seen in the
structural and spectroscopic studies of molybdopterin bio-
synthetic enzyme MoaA.37,43,49 The auxiliary cluster in TYW1
is predicted to be ligated by three cysteine residues, leaving an
open coordination site.50,51
Two competing mechanisms have been proposed for how
TYW1 uses its [4Fe−4S] clusters to form the tricyclic ring of
wyosine derivatives (Scheme 2). In one mechanism, pyruvate is
activated by forming a Schiﬀ base to a conserved Lys residue in
the active site. Hydrogen atom abstraction from the methyl
group of m1G by the dAdo• radical,32 which has been
demonstrated biochemically, results in production of 5′-
deoxyadenosine (dAdoH) and a methylene radical. The
methylene radical in turn attacks the C2 of the immobilized
pyruvate. Homolytic cleavage of the C1−C2 bond of pyruvate
eliminates the equivalent of a carbon dioxide anion radical. The
carbon dioxide anion radical may then be oxidized to form
carbon dioxide or reduced to form formate, with the auxiliary
cluster possibly playing a role. The exocyclic amino group at C2
of guanosine resolves the Schiﬀ base in a transimination
reaction that regenerates the active site Lys for a subsequent
turnover cycle.32,33
A competing mechanism has been proposed that discounts
the role of the conserved Lys residue, proposing, on the basis of
spectroscopic studies, that the auxiliary cluster alone facilitates
the activation of pyruvate (Scheme 2).35,52 In this proposal,
hydrogen atom abstraction also occurs at the methyl group of
Scheme 1. Biosynthetic Pathway for imG-14
Scheme 2. Two Hypothesized Mechanisms for TYW1
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m1G, consistent with the biochemical data,32 and the resulting
radical species forms a bond with C2 of pyruvate, prompting
homolytic cleavage of the C1−C2 bond of pyruvate. In this
mechanism, decarboxylation is concomitant with reduction of
the auxiliary cluster to form carbon dioxide. The auxiliary
cluster is proposed to catalyze the formation of the imidazoline
ring by activating the keto oxygen for elimination upon
transimination.35,36 This mechanism does not provide a direct
role for a catalytically essential lysine, which is proposed to play
an indirect role in modulating the redox properties of the
cluster.36,37
A key diﬀerence between the two proposed mechanisms is
the involvement of a Schiﬀ base in mechanism 1. Here we
employ crystallography and biochemistry to investigate the
formation of a Schiﬀ base between the conserved Lys in TYW1
and pyruvate.
■ EXPERIMENTAL PROCEDURES
Expression of Tobacco Etch Virus (TEV) Protease. The
Escherichia coli SG1300009 pLacIRARE cell line was transformed
with TEV (both generous gifts from Hazel Holden at University of
WisconsinMadison)53 and plated on a lysogeny broth-Lennox (LB)
agar plate containing 34 μg/mL chloramphenicol and 100 μg/mL
ampicillin. A single colony from this plate was used to inoculate a 150
mL culture of LB containing 34 μg/mL chloramphenicol and 100 μg/
mL ampicillin that was grown overnight at 37 °C with shaking at 225
rpm.
The overnight culture was used to inoculate 12 2.8 L Fernbach
ﬂasks, each containing 1 L of LB containing 34 μg/mL
chloramphenicol and 100 μg/mL ampicillin. They were grown at 37
°C with shaking at 200 rpm until OD600 ∼ 0.6. The temperature was
set to 16 °C, and protein expression was induced by addition of
isopropyl ß-D-1-thiogalactopyranoside to a ﬁnal concentration of 0.1
mM. After 18 h, cells were harvested by centrifugation and ﬂash frozen
with liquid N2.
Puriﬁcation of TEV Protease. TEV protease was puriﬁed at 4 °C.
Approximately 30 g of cells were resuspended in 50 mM potassium
phosphate (KPi) (pH 7.4) buﬀer containing 0.5 M potassium chloride
(KCl), 20 mM imidazole, 20% (v/v) glycerol, and 1 mM
phenylmethane sulfonyl ﬂuoride (PMSF). Cells were lysed using a
Branson soniﬁcator at 50% amplitude with 15 s on and 59.9 s oﬀ, for a
total of 12 min of lysis time, while stirring on ice. Cell lysate was
clariﬁed via centrifugation at 18,500 × g at 4 °C for 30 min.
The clariﬁed lysate was loaded onto a 5 mL HiTrap chelating HP
column charged with nickel sulfate and preequilibrated in 50 mM KPi
(pH 7.4) buﬀer containing 0.5 M KCl, 20 mM imidazole, and 20% (v/
v) glycerol. When all of the lysate was loaded, the column was washed
with 50 mL of the above buﬀer. Protein was eluted with a gradient to
100% 50 mM KPi (pH 7.4) buﬀer containing 0.5 M KCl, 0.5 M
imidazole, and 20% (v/v) glycerol over 40 mL.
Fractions containing protein were identiﬁed via SDS-PAGE, and the
concentrated fractions were pooled and then dialyzed against 4 L of 50
mM KPi (pH 7.4) buﬀer containing 0.5 M KCl, 20 mM imidazole, and
20% (v/v) glycerol at 4 °C with two changes. Glycerol was added to
the protein to a ﬁnal concentration of 50% (v/v), and the protein was
aliquoted and stored at −20 °C.53
Cloning and Expression of Wild Type TYW1 (wtTYW1). To
create a wtTYW1 (pAY613) construct containing a TEV protease site,
the codon optimized Methanocaldococcus jannaschii TYW1 gene was
cut from pET28a (pAY429)33 using the HindIII and NdeI cut sites and
inserted into pET28JT vector53 digested with HindIII and NdeI.
Expression of wtTYW1 was as previously described.33
Puriﬁcation of wtTYW1. wtTYW1 was puriﬁed in a Coy
anaerobic chamber (approximately 97% N2, 3% H2) at room
temperature. Cell paste was resuspended in 20 mM Tris-
(hydroxymethyl)aminomethane hydrochloride (Tris−HCl) (pH 8)
and lysed by sonicating with a Branson sonicator at 50% amplitude for
15 min lysis time with 15 s on and 45 s oﬀ. Cell lysate was clariﬁed by
centrifugation at 18,500 × g at 4 °C for 30 min.
Clariﬁed lysate was transferred to a sealed bottle and heated for 30
min in an 80 °C water bath outside the anaerobic chamber and was
then cooled for 15 min in an ice bath. The lysate was again clariﬁed by
centrifugation at 18,500 × g at 4 °C for 30 min.
Solid ammonium sulfate was added to the clariﬁed lysate to a ﬁnal
concentration of 1 M, which was loaded onto a 40 mL butyl-sepharose
FF column equilibrated in 20 mM Tris−HCl (pH 8) buﬀer containing
1 M ammonium sulfate. Following loading of the lysate, the column
was washed with equilibration buﬀer until the absorbance returned to
baseline. Adsorbed protein was eluted with a step gradient to 20 mM
Tris−HCl (pH 8), and brown fractions were pooled.
Pooled fractions were loaded onto two 5 mL HiTrap chelating HP
columns connected in series charged with nickel sulfate and
equilibrated in 50 mM KPi (pH 7.4) buﬀer containing 0.5 M KCl
and 50 mM imidazole. The column was washed with equilibration
buﬀer, and when absorbance had returned to baseline, the adsorbed
protein was eluted by a step gradient to 50 mM KPi (pH 7.4) buﬀer
containing 0.5 M KCl and 0.5 M imidazole. Brown fractions were
pooled and desalted into 50 mM piperazine-N,N′-bis(2-ethanesulfonic
acid)-sodium hydroxide (PIPES-NaOH) (pH 7.4) buﬀer containing 2
mM dithiothreitol (DTT).
The His-tag was removed by incubation overnight with TEV
protease at room temperature. The solution was then loaded onto two
5 mL HiTrap chelating HP columns connected in series, charged with
nickel sulfate, and equilibrated in 50 mM KPi (pH 7.4) buﬀer
containing 0.5 M KCl and 50 mM imidazole. The protein that ﬂowed
through the column was pooled and desalted into 50 mM PIPES-
NaOH (pH 7.4) buﬀer containing 2 mM DTT.
Protein concentrations were determined by the Bradford method,
and a correction factor of 0.32 was applied.32 Reconstitution of iron
sulfur clusters was performed with desalted TYW1 by stirring at room
temperature in the presence of 10 molar equivalents of iron(III)
chloride and sodium sulﬁde for 4 h. Precipitated protein was then
removed by centrifugation, and the protein was desalted into 50 mM
PIPES-NaOH (pH 7.4) buﬀer containing 150 mM KCl and 2 mM
DTT.
Desalted protein was loaded onto a Sephacryl 16/60 S-200 column
equilibrated in 50 mM PIPES-NaOH (pH 7.4) buﬀer containing 150
mM KCl and 2 mM DTT. The peak corresponding to monomeric
protein was pooled, concentrated, and ﬂash frozen with liquid N2.
Expression of His-Tagged TYW1. TYW1 with an N-terminal
His-tag was expressed using pAY429 as previously described.33
Puriﬁcation of TYW1. TYW1 with an N-terminal His-tag was
puriﬁed as described above for wild-type TYW1 with the following
changes. The clariﬁed lysate was heated to 80 °C in a mineral oil bath
within an anaerobic chamber in order to minimize exposure to oxygen.
The TEV cleavage step was also omitted.
Preparation of SAM. SAM was prepared as described
previously.33
Preparation of tRNA. Soluble RNA was extracted from a
YPL207W knockout strain of Saccharomyces cerevisiae as previously
described.32
Crystallization of TYW1. His-tagged TYW1 was crystallized using
the sitting-drop vapor diﬀusion method within an anaerobic chamber
(MBraun) under a nitrogen atmosphere (O2 < 0.1−1.2 ppm) at 21 °C.
All sparse matrix screening was performed using a Mosquito pipetting
robot (TTP LabTech). In order to obtain data quality crystals, a
microseed matrix screening technique was utilized. A microcrystal seed
stock was prepared by mixing 1 μL of protein solution (containing 8
mg/mL of TYW1, 50 mM PIPES pH 7.4, 150 mM KCl, 2 mM DTT,
and 5 mM SAM) with 1 μL of reservoir solution (0.2 M K/Na tartrate
tetrahydrate, 25% (w/v) PEG 3350). The very thin plate-like crystals,
which appeared after 24 h, were harvested by pipetting the entire drop
(2 μL in total) into a seed bead tube (Hampton Research) containing
50 μL of stabilization solution (0.2 M potassium sodium tartrate
tetrahydrate, 30% (w/v) PEG 3350). After vortexing for 2 min, 450 μL
of stabilization buﬀer was added to the tube to make the seed stock
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and serial dilutions were performed to prepare a 100-fold and a 1000-
fold dilution for the microseed matrix screening experiments.
Data quality crystals were obtained in the screening tray by mixing
0.25 μL of protein solution (containing 9.7 mg/mL of TYW1, 50 mM
PIPES pH 7.4, 150 mM KCl, 2 mM DTT, and 5 mM SAM) with 0.2
μL of reservoir solution (100 mM KH2PO4/Na2HPO4 pH 6.2, 10%
(w/v) PEG 3000) and 0.05 μL of the 1000-fold diluted seed stock and
incubating the mixture over a 70 μL reservoir. Dark-brown rod-like
(50 μm × 100 μm × 40 μm) crystals appeared after 2 days. The tray
was transferred to a Coy laboratory products’ anaerobic chamber at 24
°C and under a 95% argon, 5% hydrogen atmosphere, for harvesting.
Crystals were cryoprotected by transferring them in four steps of
increasing glycerol concentration into a cryogenic solution containing
100 mM KH2PO4/Na2HPO4 pH 6.2, 15% (w/v) PEG 3000, and 20%
(v/v) glycerol before ﬂash freezing in liquid nitrogen.
Structure Determination of TYW1. A native data set of TYW1
was collected at the Advanced Photon Source (Argonne, IL) on
beamline 24-ID-C using the Pilatus-6M pixel array detector at a
wavelength 0.9792 Å (12662 eV) and a temperature of 100 K. During
data collection, the crystal was continuously translated along its major
macroscopic axis, using the continuous vector strategy. Data were
indexed, integrated, and scaled in HKL200054 in the spacegroup
P212121 to 1.64 Å resolution.
An initial model of TYW1 containing one molecule in the
asymmetric unit was solved by molecular replacement in Phaser55
(LLG and TFZ scores of 1763.8 and 41.8, respectively) using the
previously published structure of TYW1 from Methanocaldococcus
jannaschii (PDB 2Z2U) as an all atom search model and the full
resolution of the processed data set. After one round of rigid body
reﬁnement, ill-ﬁtting sections of the initial model were deleted and the
resulting model was subjected to 10 rounds of simulated annealing to
minimize existing model bias. Iterative rounds of model building into
unambiguous electron density and reﬁnement were performed in
Coot56 and Phenix,57 respectively. In the initial stages of reﬁnement,
Coot was used to place the iron sulfur clusters, whereas water
molecules were manually added during advanced stages of reﬁnement.
Positive Fo−Fc diﬀerence density was used to guide the modeling of
the covalent adduct formed at K41. A new residue was created by
merging a pyruvate molecule and lysine molecule to produce a Schiﬀ
base ligand, KAC, in Jligand.58 Coot was used to dock the ligand into
the structure. In addition to preparing the residue, respective link
records and CIF ﬁles used during docking and reﬁnement were
prepared in Jligand.
Veriﬁcation of the ﬁnal structure was guided by simulated annealing
composite omit maps and analysis of Ramachandran and rotamer
outliers. Side chains without visible density were stubbed at the last
visible atom, and residues without unambiguous electron density were
not included in the model. This reﬁnement procedure resulted in a
ﬁnal structure of TYW1 that includes residues 0−72, 82−255, and
260−311 (of 331 residues including the puriﬁcation tag and linker), a
[2Fe−3S] radical SAM cluster, and a [4Fe−4S] auxiliary cluster. It
contained 96.9% of its residues in the most favored region of the
Ramachandran plot, 3.1% in the additionally favored region, and 0.0%
in the outlier region. Rwork and Rfree are 0.1760 and 0.2024,
respectively. All reﬁnement statistics are summarized in Table S1.
The radical SAM and the auxiliary clusters were reﬁned with
occupancies of 0.84 and 0.58, respectively, indicating that about 80%
of molecules in the crystal contained a [2Fe−3S] radical SAM cluster
and about 60% have a [4Fe−4S] auxiliary cluster bound. We observed
electron density that was best ﬁt by a double conformation of the
pyruvate−lysine adduct species (Figure S1A,B). In the major
conformation (reﬁned occupancy of 0.57), the Schiﬀ base is ligated
to the auxiliary cluster. However, in the minor conformation (reﬁned
occupancy of 0.43), the pyruvate moiety is rotated such that the
carboxylate group is facing the Schiﬀ base binding pocket and the
methyl group is facing the auxiliary cluster (Figure S1C). We posit that
the minor conformation of the Schiﬀ base exists in the 40% of the
molecules that also lack an auxiliary cluster, and is stabilized through
side chain interactions (Figure S1D). The remainder of this
manuscript will focus on the dominant conformation of the Schiﬀ
base species.
Visualization of a [2Fe−3S] radical SAM cluster was unexpected
given that the protocols used for both anaerobic cluster reconstitution
and anaerobic crystallization are the same as those that have been used
successfully previously59,60 and given that the auxiliary cluster of
TYW1 is intact. Thus, the source of the diﬃculty in observing an intact
radical SAM cluster is not obvious. Density for SAM was not apparent
in the structure of TYW1, although SAM was present in the
crystallization mixture. The absence of SAM in the structure is likely
due to cluster disorder. Many unsuccessful attempts were made to
obtain a structure of holo-TYW1 with SAM bound (data not shown).
Therefore, substrate bound models of TYW1 were achieved by manual
docking in Coot.
To model the radical SAM cluster and the bound SAM, the
corresponding regions of the MoaA structure (PDB 1TV8) were used
as a guide. Protein ﬁgures were generated in PyMol,61 and electrostatic
calculations were performed with the APBS plugin62 within PyMol.
Cloning and Puriﬁcation of C195S and K41A TYW1 Mutants.
C195S and K41A TYW1 mutants were created following the
Stratagene QuikChange site-directed mutagenesis protocol and
pAY613 as a template. To create the K41A mutant, the following
primers were used, 5′-CAAAAACTGTTACGCATCAAAATTCTAC-
3′ and 5′-GTAGAATTTTGATGCGTAACAGTTTTTG-3′, with the
mutated bases shown in bold. To create the C195S mutant, the
following primers were used, 5′-CCTACCGTCGCATTTCC-
GGCGGTAAAAAAGAATAC-3′ and 5′-GTATTCTTTTTTACC-
GCCGGAAATGCGACGGTAGG-3′, with the mutated bases shown
in bold. The mutant proteins were expressed and puriﬁed as described
above for wtTYW1.
Activity Assays of C195S and K41A Variants. The assays were
performed in 0.1 M Tris−HCl (pH 8), 0.1 M KCl, 4 mM DTT, 2 mM
SAM, 2 mM pyruvate, 10 mM sodium dithionite, 1.5 mM methyl
viologen, 200 μg of yeast tRNA, and 100 μM protein. The reactions
were incubated at 50 °C overnight. The RNA was extracted and
digested to the nucleoside level as previously described. The resulting
nucleotide mixture (20 μL) was injected onto a Thermo Vanquish
UHPLC interfaced with a Thermo LTQ OrbiTrap XL. The analytes
were separated on a Thermo hypersil gold C18 column (150 × 2.1
mm2) equilibrated in 50 mM ammonium acetate (pH 6) (solution A).
Solution B consisted of 40% acetonitrile (Fisher Optima LC/MS
grade). The separation program was as follows with a ﬂow rate of 200
μL/min: 0−3 min, 0% B; 3−3.25 min, 0−0.2% B; 3.25−3.5 min, 0.2−
0.8% B; 3.5−3.75 min, 0.8−3.2% B; 3.75−4 min, 3.2−5% B; 4−7 min,
5−25% B; 7−10 min, 25−50%; 10−12 min, 50−75% B; 12−12.1 min,
75−100% B; 12.1−15 min, 100% B; 15−15.1 min, 100−0% B; 15.1−
18 min, 0% B. The LTQ OrbiTrap XL was operated in positive ion
mode with the FT analyzer set to a resolution of 100,000.
Trapping of Schiﬀ Base in TYW1. The assays to trap the Schiﬀ
base intermediate were performed in 0.1 M Tris−HCl (pH 8.0) buﬀer
containing 0.1 M KCl, 4 mM DTT, 2 mM SAM, 10 mM pyruvate
(either 1,2,3-13C3-pyruvate or 1-
13C1-pyruvate), 10 mM sodium
dithionite, 1.5 mM methyl viologen, 200 μg of yeast tRNA, 10 mM
sodium cyanoborohydride (NaCNBH3) or sodium cyanoborodeuter-
ide (NaCNB2H3) (freshly prepared), and 100 μM C195S-TYW1. The
reactions were incubated for 7 h in the glovebox at room temperature.
Following the incubation, 20 units of trypsin (bovine pancreas)
dissolved in 100 mM Tris−HCl (pH 8.0) was added to each assay, and
assays were incubated at room temperature overnight. The following
day, DTT was added to a ﬁnal concentration of 9.5 mM and assays
were incubated for 45 min at 56 °C. The reactions were cooled to
room temperature, 2-iodoacetamide, dissolved in 100 mM ammonium
bicarbonate, was added to a ﬁnal concentration of 23 mM, and assays
were incubated in the dark at room temperature for 30 min. Trypsin
and other large molecules were removed by ﬁltration through a PES
10K centrifugal ﬁlter, and 80 μL of the ﬁltrate was injected onto a
Thermo Vanquish UHPLC interfaced with a Thermo LTQ OrbiTrap
XL. The analytes were separated on a Thermo hypersil gold C18
column (150 × 2.1 mm2) equilibrated in 0.1% TFA (Fisher Optima
LC/MS grade) (solution A). Solution B consisted of acetonitrile:0.1%
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TFA (Fisher Optima LC/MS grade). The separation program was as
follows with a ﬂow rate of 200 μL/min: 0−1 min, 0% B; 1−6.5 min,
0−30% B; 6.5−6.6 min, 30−100% B; 6.6−9.6 min, 100% B; 9.6−9.7
min, 100−0% B; 9.7−12.7 min, 0% B. The LTQ OrbiTrap XL was
operated in positive ion mode with the FT analyzer set to a resolution
of 100,000.
Controls to determine which components were required for the
trapping of a Schiﬀ base were carried out as described above in the
presence of 1,2,3-13C3-pyruvate and either NaCNBH3 or NaCNB
2H3
in the absence of one of the following components, SAM, sodium
dithionite, or tRNA. The resulting protein was analyzed as described
above.
The Schiﬀ base trapping assay was repeated with wtTYW1 to ensure
that the wild type protein formed the same adduct as the C195S
protein. The assay was repeated as described above using wtTYW1
instead of C195S-TYW1.
■ RESULTS
Overall Architecture of holo-TYW1. To investigate the
molecular architecture of holo-TYW1, a structure of anaerobi-
cally puriﬁed and reconstituted TYW1 from Methanocaldococcus
jannaschii was solved to 1.6 Å resolution (Figure 1). TYW1
crystallizes as a functional monomer with the structural core
adopting a partial (β/α)6 TIM barrel, the radical SAM core fold
found in most members of the radical SAM super-
family.40,42,50,51,63−72 This core fold includes a loop that follows
β1 and provides the three cysteines, C62, C66, and C69, of the
CX3CXϕC motif for binding the canonical radical SAM cluster
(where ϕ is a conserved aromatic residue).73 In TYW1, the
core fold is extended by the addition of N- and C-terminal
extensions, which ﬂank either side of the partial TIM barrel
architecture (Figure 1). The N-terminal extension begins with
α1′, which folds into an antiparallel β-hairpin (β1′ and β2′) that
extends the inner face of the partial barrel. β2′ is followed by
two α-helices, α2′ and α3′, which sit below the base of the N-
terminal region of the radical SAM domain, creating a binding
site for a second, or auxiliary, iron−sulfur cluster. On the other
side of the radical SAM domain, the C-terminal extension folds
into a nonconsecutive antiparallel β-sheet, β7′ and β8′, where
β8′ is found adjacent to β6 (of the radical SAM domain). The
C-terminal extension expands the inner face of the active site,
and with α3′ of the N-terminal extension helping to seal oﬀ the
bottom of the barrel.
In this structure, we observe one intact and one partial
[4Fe−4S] cluster. The canonical [4Fe−4S] radical SAM cluster
is not intact and is best accounted for by a [2Fe−3S] cluster
(Figure 1A) with a water molecule as the fourth ligand,
suggesting either cluster degradation or incomplete cluster
reconstitution. In contrast, the auxiliary cluster is an intact
[4Fe−4S] cluster coordinated by three conserved cysteines,
C26, C39, and C52 (Figures 1A,B and 2A).
Two apo structures of TYW1 from Methanocaldococcus
jannaschii (apo-MjTYW1)50 and Pyrococcus horikoshii (apo-
PhTYW1)51 have been previously reported to 2.4 and 2.2 Å
resolution, respectively. These two structures are very similar to
our MjTYW1 structure, with a rmsd of 0.56 Å for apo-
MjTYW1 and 0.94 Å for apo-PhTYW1 (calculated by
alignment of 222 out of 280 and 234 out of 325 alpha carbons,
respectively, using PyMol61). A key diﬀerence between these
structures and ours is the increased iron−sulfur cluster content
in our structure, but the previous structures did correctly
predict the locations of the cluster-binding sites on the basis of
the clustering of conserved Cys residues.50,51 Interestingly,
outside of the other TYW1 structures, the closest structural
homologue with a Z-score of 15 and a rmsd of 3.8 Å is RlmN, a
radical SAM enzyme involved in the methylation of rRNA and
recently discovered to also methylate tRNA.68,74 Additional
structurally similar enzymes are pyruvate formate lyase
activating enzyme (PFL-AE, Z-score of 14.5 and rmsd of 3.0
Å), viperin (Z-score 12.4 and rmsd of 3.5 Å), MoaA (Z-score
12.0 and rmsd of 3.5 Å), and QueE (Z-score of 11.8 and rmsd
of 3.8 Å).
Visualization of a Schiﬀ Base Intermediate in
Crystallo. Sequence analysis correctly predicted incomplete
Cys ligation of the auxiliary cluster;35,50 only three cysteine
residues are conserved (C26, C39, and C52) outside of the
canonical radical SAM cluster binding CX3CXϕC motif, and we
ﬁnd that only these three conserved cysteine residues
Figure 1. Overall architecture of TYW1. (A) TYW1 adopts a partial (β/α)6 TIM barrel fold (light pink), which is expanded at both the N-terminus
(light blue) and the C-terminus (light orange). The radical SAM cluster and auxiliary [4Fe−4S] cluster are shown as spheres (iron in orange and
sulfur in yellow) surrounded by 2Fo−Fc electron density contoured at +1 σ (blue). When the radical SAM cluster is reﬁned as a [4Fe−4S] cluster,
negative diﬀerence density (−3 σ, red) is visible, suggesting either incomplete assembly of the cluster or partial cluster degradation. The location of
K41 is also shown. (B) Topology diagram of the overall structure of TYW1, colored as in part A. The cysteine ligands to the clusters are shown as
yellow spheres. The position of K41 is represented as a blue sphere.
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coordinate this auxiliary [4Fe−4S] cluster (Figure 2A,B). In
contrast to predictions, however, there is not an open
coordination site on the auxiliary cluster. Instead, we ﬁnd the
catalytically essential residue, K41,50 in close proximity (∼2.8
Å) to the unique iron of the auxiliary cluster (Figure 2A).
During iterative rounds of reﬁnement and model building,
positive diﬀerence density extending from the Nz of K41
toward the unique iron of the auxiliary cluster appeared (Figure
2A). Guided by this diﬀerence density, we modeled in and
reﬁned the Schiﬀ base intermediate predicted to form32,33
between a lysine residue and the pyruvate substrate during
catalysis.32,33 We found that a pyruvate−lysine adduct accounts
well for the density (Figure 2B). It must be noted that the
density observed for the adduct can also accommodate a
reduced Schiﬀ base, and therefore, we cannot rule out the
possibility that the species observed is an amine rather than an
imine. Regardless, this covalent Schiﬀ base adduct places the
oxygen of the carboxylic acid of pyruvate and the Nz of lysine
about 2.4 and 2.3 Å away from the unique iron of the auxiliary
cluster, respectively, creating a bidentate ligation reminiscent of
SAM binding to the radical SAM clusters of members of the
superfamily40,43,59,60,67,72,75−78 (Figure 2C,D).
In addition to interactions with the unique iron, the Schiﬀ
base is stabilized in the active site through water hydrogen
bonds (Figure 3A). At a distance of 2.5 and 3.0 Å, a water
molecule bound by Q54 and S134 provides contacts to the
carboxylic group of the pyruvate-derived portion of the Schiﬀ
base. Whereas stacking interactions from F160 help orient the
C3 methyl of the pyruvate−lysine adduct in the active site, the
inner face of the Schiﬀ base binding site is made up of an
intricate hydrogen bonding network between highly conserved
residues, Y40, Y45, Y180, and E248, from the N-terminal
extension and the radical SAM core. These interactions (Figure
3A) serve to orient the adduct species at the base of the active
site with C2 of pyruvate, the site of radical attack by the m1G
substrate radical, 12.6 Å away from the radical SAM cluster.
SAM Binding Motifs Appear to Be Conserved. We
modeled the missing atoms of the radical SAM cluster using the
positions of the cluster atoms that we could observe and
modeled SAM binding to the cluster using the structure of
MoaA (PDB 1TV8) as a guide (Figure S2). In particular, SAM
was positioned such that its amino group and its carboxylic
group were 2.3 and 2.0 Å from the unique iron, respectively.
SAM was also positioned in a catalytically competent
Figure 2. A Schiﬀ base intermediate in TYW1 is visualized. (A) An
intact [4Fe−4S] auxiliary cluster is shown surrounded by 2Fo−Fc
electron density, contoured at 1 σ (blue). Three cysteine ligands, C26,
C39, and C52, bind the auxiliary cluster, producing a site diﬀerentiated
iron ion, which is in close proximity to K41. A positive diﬀerence
density (green) contoured at +3 σ is shown extending from Nz of K41
to the unique iron. (B) To account for diﬀerence electron density, a
Schiﬀ base between K41 and the substrate pyruvate (KAC41) was
modeled and reﬁned. A 2Fo−Fc omit density map (cyan) contoured
at 1 σ is shown for the auxiliary cluster, cysteine ligands, and covalent
adduct. (C) The Schiﬀ base intermediate, KAC41, ligates the unique
iron of the auxiliary cluster of TYW1 in a bidentate fashion through
interactions with the Nz atom (blue) and a carboxylic oxygen (red).
(D) SAM ligating the unique iron of the SAM cluster in MoaA (PDB
1TV8), utilizing the amino nitrogen (blue) and a carboxylic oxygen
(red). All residues are shown as sticks.
Figure 3. TYW1 active site structure and models. (A) The binding
pocket of KAC41 is shown, with interactions represented as dashed
lines. (B) SAM molecule (slate) modeled in the active site with dashed
lines indicating potential hydrogen bonds. The positions of classic
SAM radical motifs are labeled. (C) m1G (teal) modeled into the
active site with potential interacting residues shown as sticks. (D) The
m1G (teal) modeled structure from panel C is shown in a diﬀerent
orientation with the dashed lines highlighting the distances between
the sites of hydrogen atom abstraction.
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orientation with the S atom poised 3.2 Å from the unique iron.
We ﬁnd that, when SAM is positioned in this classic orientation
with respect to the radical SAM cluster, SAM can make the
traditional interactions with the SAM-binding motifs.75,76,79 For
example, a carbonyl from the “GGE” motif, S136G137E138 in
TWY1, is available to hydrogen bond to the amide of SAM, and
D184 (ribose motif) and R221 are positioned to interact with
the ribose hydroxyl groups of SAM either through a water
molecule or hydrogen bond, respectively (Figure 3B). Residues
T223 (GXIXGXXE motif) and F68 (ϕ in the CX3CXϕC
motif) are found in close proximity to the adenine moiety of
modeled SAM and can provide hydrophobic interactions to
orient the adenine ring. In addition, backbone atoms are
positioned to make classic interactions, M251 (β6 motif) and
F68 (CX3CXϕC motif), to the N1, N6 exocyclic amine and N7
of the adenine moiety (Figure 3B).
A Positive Electrostatic Surface near the Active Site
Suggests the Location of the tRNA Binding Site. The
nucleotide modiﬁed by TYW1, m1G37, is part of the ACSL of
tRNAPhe, which when bound to its modifying enzyme is
expected to adopt a tRNA bulge conformation that has m1G37
ﬂipped out of the loop.74,80 Due to its negatively charged
phosphate backbone, the ACSL should bind a positively
charged site on the protein. Electrostatic calculations (Figure 4)
show a large region of positive electrostatic charge that leads
from the active site cavity to the tip of the N-terminal extension
near α3′ and α1a (Figure 4). Modeling suggests that this patch
of positive charge is appropriately the correct size for a 20-base-
pair ACSL (Figure 4). In this model, the m1G37 sits on top of
the active site with the rest of the ACSL extended along the
positively charged protein surface (Figure 4). The active site of
TYW1 is solvent exposed in the absence of nucleotide
substrate, but the binding of a tRNAPhe molecule to TYW1
would be expected to close oﬀ the active site, making it less
accessible to solvent.
There is a space in between SAM and the Schiﬀ base in the
active site cavity that is a suitable size for a m1G binding site
(Figure 3C,D). Modeling m1G into this putative binding site
positions the N1-methyl group of m1G (the site of hydrogen
atom abstraction by dAdo•) 3.2 Å away from the C-5′ of SAM
(Figure 3D). The N1-methyl group is also 4.9 Å from the C2 of
the pyruvate-derived portion of the Schiﬀ base intermediate
(Figure 3D). In this location, the base of m1G would be capable
of making π−π stacking interactions with the adenine ring of
SAM and forming hydrogen bonds (∼2.4 Å) between O6 and
R221 and (∼2.9 Å) between N7 and K250 (Figure 3C). The
phosphate group could be stabilized by hydrogen bonding
interactions with K24, distance modeled at 2.6 Å (Figure 3C).
In Vitro Activity of C195S and K41A TYW1 Mutants.
K41 has been shown previously to be essential in vivo,50 and
here we wanted to verify that a K41A variant protein is unable
to produce imG-14 in vitro. As a control, we also prepared a
C195S TYW1 variant. C195 is adjacent to the radical SAM
cluster but is not a direct cluster ligand. The extracted ion
chromatogram at m/z 322 (imG-14 [M + H+]) obtained when
C195S TYW1 (red), wild type TYW1 (black), and K41A
TYW1 (blue) are incubated in the presence of tRNA,
reductant, SAM, and pyruvate is shown in Figure 5. There is
a peak present in both the wild type and C195S samples that is
not present in the negative control (no enzyme) or in the K41A
sample that corresponds to imG-14. Therefore, at least under
the conditions of the assay, C195S variant is catalytically active
and K41A is not active. This ﬁnding supports the importance of
K41 in catalysis. The C195S variant is used in the subsequent
Schiﬀ base trapping experiments.
In Vitro Trapping of a Schiﬀ Base Intermediate Using
C195S-TYW1. To unambiguously demonstrate formation of a
Schiﬀ base between TYW1 and pyruvate, C195S-TYW1 was
incubated with NaCNBH3 and NaCNB
2H3 in the presence of
SAM, reductant, and substrate. Reactions were treated with
iodoacetamide prior to tryptic digestion to ensure that
oxidation of cysteines did not occur. The shortest tryptic
fragment of TYW1 containing a pyruvate-modiﬁed K41 would
be NCYK, where K denotes the modiﬁed K41 and C denotes a
carbamidomethylated cysteine residue. Since a modiﬁed K at
the cleavage site for trypsin may lead to a missed cleavage, we
also considered that the shortest observable fragment would be
NCYKSK. The fragment NCYK would have m/z 584.2497 [M
+ H+], while modiﬁcation of the lysine, NCYK, would shift the
mass of the peptide to m/z 656.2708 [M + H+]. The fragment
NCYKSK peptide should have m/z of 799.3767 [M + H+],
whereas a pyruvate-modiﬁed lysine, NCYKSK, would shift the
mass to m/z 871.3978 [M + H+].
The ability of TYW1 to form a Schiﬀ base with pyruvate was
investigated by incubating the enzyme under anaerobic
conditions in a mixture that contained all components of the
assay, including pyruvate, yeast tRNA, methyl viologen,
dithionite, and SAM. In addition, NaCNBH3 was also added
Figure 4. Electrostatic surface of TYW1. The surface of TYW1 is
colored on the basis of its electrostatic properties with positively
charged areas in blue and negatively charged areas in red. A path of
positive electrostatic surface leads from the active site to a putative
binding site for tRNAPhe. SAM (C in slate) and KAC41 (C in light
blue) are shown in sticks. A model of a 20-base-pair tRNA anticodon
stem loop (PDB 1EHZ in orange) is shown against this surface. The
site of tRNA base modiﬁcation, m1G37 (C in teal), is shown as sticks
in the active site.
Figure 5. Activity of TYW1 with RNA. The extracted ion
chromatogram from m/z 322.1 to 322.12 showing that imG-14
forms in the presence of wildtype TYW1 and the C195S variant but
not with K41A or when TYW1 is not included in the assay.
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in the incubations to stabilize the Schiﬀ base that forms by
reduction. The samples were digested with trypsin, the cysteine
residues alkylated, and the resulting fragments subjected to LC-
MS analysis, following the incubations. The extracted ion
chromatograms (Figure S3) reveal a peak at m/z 871,
corresponding to NCYKSK, as well as a peak at m/z
584.2497, corresponding to NCYK. These results were
encouraging, as they suggested that the K could be modiﬁed;
however, we could not eliminate the possibility that the
modiﬁed K was present in the puriﬁed enzyme.
To determine the source of the pyruvate appended to K41,
identical incubations were carried out with 1,2,3-13C3-pyruvate.
The resulting extracted ion chromatograms (Figure S4) reveal
peaks at m/z 874, which would be expected for a NCYKSK
fragment where the 1,2,3-13C3-pyruvate is present. Interestingly,
we also observe a signiﬁcant peak at m/z 871, which
corresponds to unlabeled pyruvate appending K41. This peak
likely results from pyruvate that is adventitiously bound to the
enzyme through K41. In fact, we point out that the structure of
the pyruvate-modiﬁed K41 reported above was solved with
protein that had never been incubated with pyruvate in vitro,
and was likely puriﬁed with the Schiﬀ base that had formed
during protein production in vivo, or during the puriﬁcation and
reconstitution of the protein under reducing conditions.
To further conﬁrm that the peak at m/z 874 corresponds to
NCYKSK, which is obtained by pyruvate modiﬁcation and
subsequent reduction with NaCNBH3, we repeated the
experiment with NaCNB2H3. In this experiment we would
expect that the peak at m/z 874 that is observed with
1,2,3-13C3-pyruvate would shift to 875 in the presence of
NaCNB2H3. Indeed, as predicted, when TYW1 was incubated
in the presence of cyanoborohydride, the m/z peak for
NCYKSK shifted from 874.4085 to 875.4156, which is within
1 ppm of the theoretical mass of the peptide containing three
13C and one 2H atoms (Figure 6A and B). These data
unambiguously show that pyruvate can modify K41 to a Schiﬀ
base.
In the experiments with the NaCNB2H3 and 1,2,3-
13C3-
pyruvate, as with the experiments with unlabeled reductant, we
also observe a peak at 871.399 corresponding to NCYKSK that
does not undergo reduction. This result suggests that the pool
of pyruvate-modiﬁed K41 that we observe is already reduced in
the protein. To probe this further, we repeated the experiment
in the absence of added pyruvate (Figure 6C and D). Indeed,
the peak at 871.399 does not shift when NaCNB2H3 is used,
conﬁrming the presence of modiﬁed K41 in the sample. We
cannot eliminate the possibility that the reduction of this pool
occurs in the course of the incubation, as the structural data do
not clearly distinguish between an imine and an amine.
To determine which reaction components were required for
the Schiﬀ base to form, a series of control reactions were set up
with TYW1 in the presence of 1,2,3-13C3-pyruvate and either
NaCNBH3 or NaCNB
2H3 (Figure S5). The controls show that
SAM, dithionite, or tRNA are not required, as the peak at m/z
874.4085 ± 1 ppm (with NaCNBH3) or m/z 875.4148 ± 1
ppm (with NaCNB2H3) is present in all of the samples.
Therefore, the formation of the Schiﬀ base is not dependent
upon the presence of the tRNA or the oxidation state of the
cluster, which is in agreement with previously published
spectroscopic studies that show changes in the environment
of the auxiliary cluster in the presence of pyruvate in the
absence of SAM or reductants.35,52
■ DISCUSSION
The mechanism by which TYW1 catalyzes the addition of two
carbon atoms from pyruvate to extend the ring of m1G37,
forming the characteristic imidazopurine of the wyosine bases
found in tRNAPhe, has been disputed.32−36,52 Although both
mechanistic paradigms suggest a role for the auxiliary cluster in
activating pyruvate, one suggests a more intimate interaction
between TYW1 and pyruvate, which is mediated by a Schiﬀ
base linkage. Herein, we present biochemical and structural
evidence to support a role for a Schiﬀ base in the reaction
catalyzed by TYW1.
Our structure presents the ﬁrst snapshot of the active site of
TYW1 with iron sulfur clusters bound. This structure reveals
electron density for an auxiliary [4Fe−4S] cluster coordinated
by the three conserved cysteines, conﬁrming the results of a
previous EPR and Mossbauer study. As predicted, the
conserved and catalytically important K41 is found in close
proximity to the unique iron of the auxiliary cluster. K41 has
been shown previously to be essential for in vivo activity;50 the
recombinant K41A variant is shown here to be catalytically
inactive, further emphasizing its essential role. We observe
electron density consistent with pyruvate forming a Schiﬀ base
intermediate with K41 and ﬁnd that the adduct is within
hydrogen bonding distance of the cluster, consistent with
earlier EPR and Mossbauer studies.35,52 In addition, the
chemical in vitro trapping of a pyruvate−lysine adduct using
pyruvate, 1,2,3-13C3-pyruvate, and either NaCNBH3 or
NaCNB2H3 further conﬁrms that TYW1 is able to form a
Schiﬀ base intermediate between pyruvate and K41, which is in
line with mechanism 1 in Scheme 2.
A mechanistic paradigm for TYW1 that is consistent with all
structural, biochemical, and spectroscopic evidence to date is
shown in Scheme 3. A Schiﬀ base between K41 and pyruvate is
proposed to precede the reductive cleavage of SAM and the
subsequent hydrogen abstraction from m1G. The resulting m1G
methylene radical can attack the C2 of the cluster-bound Schiﬀ
base, forming a new C−C bond and leading to a subsequent
decarboxylation.
Although the fate of C1 of pyruvate remains to be
established, the ligation of the Schiﬀ base to the cluster sets
up the adduct for one electron oxidation by the auxiliary cluster,
Figure 6. Mass spectrum of a tryptic fragment of TYW1. TYW1
incubated with (A) 1,2,3-13C3 pyruvate in the presence of NaCNBH3,
(B) 1,2,3-13C3 pyruvate in the presence of NaCNB
2H3, (C) no
pyruvate in the presence of NaCNBH3, and (D) no pyruvate in the
presence of NaCNB2H3.
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which would lead immediately to decarboxylation to carbon
dioxide. Reduction of the cluster and concomitant formation of
carbon dioxide would place the cluster in the +1 oxidation state,
which is in agreement with previous Mossbauer and EPR
studies.35,52 For subsequent turnover cycles, ﬂavodoxin could
reoxidize the auxiliary cluster and potentially deliver the
electron back to the radical SAM cluster, preparing it for the
next round of catalysis, as has been observed in AtsB and
anSMEcpe.81
Visualization of a Schiﬀ base intermediate raises the question
of why TYW1 needs both a Schiﬀ base intermediate and an
iron sulfur cluster in wyosine base formation, when either in
theory is suﬃcient to perform the requisite chemistry; both can
act as an electron sink during catalysis, and both can bind and
appropriately orient the substrate. Hints may be found in
revisiting the roles of Schiﬀ base intermediates in biochemistry
and the structure of TYW1. Schiﬀ bases are used enzymatically,
producing a highly reactive imine intermediate. As in other
radical SAM enzymes, the core of TYW1’s structural
architecture is comprised of a partial (β/α)6 TIM barrel
which buries the active site within the inner face of the barrel.
This enclosure of the active site serves to sequester the reactive
radical species produced during catalysis and decrease oﬀ
pathway interactions, a strategy used by both radical SAM
enzymes and cobalamin dependent enzymes. In TYW1, the
active site cavity is largely solvent exposed but would be sealed
oﬀ with binding of the bulky tRNA substrate. The active site
cavity as well as the surface leading from the active site cavity is
largely positively charged, and tRNA is predicted to bind with
the anticodon stem loop making contact with this positive
patch of protein surface, orienting the anticodon loop to sit on
top of the active site. Binding of the tRNA will not only
eﬀectively seclude the active site from solvent, but it will also
impede the diﬀusion of substrates into the active site. No other
channel for substrate entry into TYW1 has been found, and it is
possible that all three substrates, SAM, pyruvate, and tRNAPhe,
access the active site through the opening observed in the
structure. This active site architecture imposes an order of
binding on the substrates, as the negatively charged pyruvate
molecule and SAM molecule will not be able to enter the active
site once tRNA is bound. Taking this idea into consideration, as
well as that TYW1 is puriﬁed with some reduced Schiﬀ base,
the Schiﬀ base in TYW1, in addition to potentially orienting the
pyruvate for chemistry, could play a role in tethering pyruvate
to the open active site that exists in the absence of the tRNA,
priming it for catalysis once the other substrates bind.
Therefore, the Schiﬀ base may be playing a complex role by
directing binding, orientation, and catalysis in TYW1.
The work presented here strongly supports a mechanistic
paradigm where a Schiﬀ base plays a central role in activating
the pyruvate for catalysis (Scheme 3). It remains to be seen if
the cluster plays a role in resolving the radical intermediate
hypothesized to be formed and exist on C1 during this
transformation. Identiﬁcation of the side product that results
from C1 (carbon dioxide or formate) will be highly informative
in this regard.
Scheme 3. Mechanism 1 Revised to Highlight Structural Features of the TYW1 Active Site
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■ CONCLUSION
Radical SAM enzymes are a treasure trove of interesting
chemical reactivity and can proceed through a wide variety of
mechanisms to facilitate challenging transformations. Our
understanding of the roles of additional cofactors in radical
SAM chemistry has been hazy at best, with most additional
cofactors having no concrete roles assigned to them. For
auxiliary [4Fe−4S] clusters, the proposed roles include
substrate binding and electron transport. In the biochemical
and structural work presented here, we provide support for a
Schiﬀ base intermediate in the catalytic mechanism of TYW1.
TYW1 is therefore emerging as a member of a subset of radical
SAM enzymes that, in addition to employing radical
mechanisms to activate their substrates, they also utilize
covalent ones.
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